{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:38:48Z","timestamp":1793497128489,"version":"4.5.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Intensiva (English Edition)"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.medine.2022.05.004","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T08:45:59Z","timestamp":1653986759000},"page":"392-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Resistance mechanisms in Gram-negative bacteria"],"prefix":"10.1016","volume":"46","author":[{"given":"J.A.","family":"Lepe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medine.2022.05.004_bib0005","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S1473-3099(17)30753-3","article-title":"Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis","volume":"18","author":"Tacconelli","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.medine.2022.05.004_bib0010","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.01076-18","article-title":"Past and present perspectives on \u03b2-lactamases","volume":"62","author":"Bush","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0015","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025239","article-title":"\u03b2-Lactamases: a focus on current challenges","volume":"7","author":"Bonomo","year":"2017","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.medine.2022.05.004_bib0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1042\/bj2760269","article-title":"A standard numbering scheme for the class A \u03b2-lactamases","volume":"276","author":"Ambler","year":"1991","journal-title":"Biochem J"},{"key":"10.1016\/j.medine.2022.05.004_bib0025","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.tips.2018.03.007","article-title":"The continuing challenge of metallo-\u03b2-lactamase inhibition: mechanism matters","volume":"39","author":"Ju","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.medine.2022.05.004_bib0030","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1128\/AAC.39.6.1211","article-title":"A functional classification scheme for beta-lactamases and its correlation with molecular structure","volume":"39","author":"Bush","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0035","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1128\/AAC.01009-09","article-title":"Updated functional classification of beta-lactamases","volume":"54","author":"Bush","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0040","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1469-0691.2007.01857.x","article-title":"Defining an extended-spectrum beta-lactamase","volume":"14 Suppl 1","author":"Livermore","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medine.2022.05.004_bib0045","article-title":"Extended-spectrum \u03b2-lactamases: an update on their characteristics, epidemiology and detection","volume":"16","author":"Castanheira","year":"2021","journal-title":"JAC Antimicrob Resist"},{"key":"10.1016\/j.medine.2022.05.004_bib0050","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s40265-019-01180-3","article-title":"Extended-spectrum \u03b2-lactamase-producing enterobacteriaceae: update on molecular epidemiology and treatment options","volume":"79","author":"Peirano","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.medine.2022.05.004_bib0055","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1574-6976.2011.00268.x","article-title":"Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance","volume":"35","author":"Woodford","year":"2011","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.medine.2022.05.004_bib0060","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.ijantimicag.2009.11.003","article-title":"Molecular epidemiology of Escherichia coli producing CTX-M beta-lactamases: the worldwide emergence of clone ST131 O25:H4","volume":"35","author":"Peirano","year":"2010","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medine.2022.05.004_bib0065","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.coph.2011.07.007","article-title":"Co-resistance: an opportunity for the bacteria and resistance genes","volume":"11","author":"Cant\u00f3n","year":"2011","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.medine.2022.05.004_bib0070","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1128\/CMR.00036-08","article-title":"AmpC beta-lactamases","volume":"22","author":"Jacoby","year":"2009","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.medine.2022.05.004_bib0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/AAC.46.1.1-11.2002","article-title":"Plasmid-determined AmpC-type beta- lactamases","volume":"46","author":"Philippon","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0080","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1093\/jac\/dkg284","article-title":"AmpC beta-lactamases: what do we need to know for the future?","volume":"52","author":"Hanson","year":"2003","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0085","doi-asserted-by":"crossref","first-page":"7753","DOI":"10.1128\/AAC.01729-15","article-title":"Complex regulation pathways of AmpC-mediated \u03b2-lactam resistance in Enterobacter cloacae complex","volume":"59","author":"Gu\u00e9rin","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0090","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/jac\/dky084","article-title":"Species-specific mutation rates for ampC derepression in Enterobacterales with chromosomally encoded inducible AmpC \u03b2-lactamase","volume":"73","author":"Kohlmann","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0095","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ijantimicag.2006.01.005","article-title":"In vivo selection of Enterobacter aerogenes with reduced susceptibility to cefepime and carbapenems associated with decreased expression of a 40 kDa outer membrane protein and hyperproduction of AmpC beta-lactamase","volume":"27","author":"Fern\u00e1ndez-Cuenca","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medine.2022.05.004_bib0100","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1093\/jac\/dkm226","article-title":"Class A carbapenemases","volume":"60","author":"Walther-Rasmussen","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0105","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1128\/CMR.00001-07","article-title":"Carbapenemases: the versatile beta-lactamases","volume":"20","author":"Queenan","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.medine.2022.05.004_bib0110","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0213-005X(14)70168-5","article-title":"Carbapenemases in Enterobacteriaceae: types and molecular epidemiology","volume":"32 Suppl 4","author":"Mart\u00ednez-Mart\u00ednez","year":"2014","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.medine.2022.05.004_bib0115","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1093\/jac\/dkz156","article-title":"KPC-31 expressed in a ceftazidime\/avibactam-resistant Klebsiella pneumoniae is associated with relevant detection issues","volume":"74","author":"Antonelli","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0120","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11908-018-0617-x","article-title":"The epidemiology, evolution, and treatment of KPC-producing organisms","volume":"20","author":"Porreca","year":"2018","journal-title":"Curr Infect Dis Rep"},{"key":"10.1016\/j.medine.2022.05.004_bib0125","doi-asserted-by":"crossref","first-page":"e00397","DOI":"10.1128\/AAC.00397-20","article-title":"Metallo-\u03b2-lactamases: structure, function, epidemiology, treatment options, and the development pipeline","volume":"64","author":"Boyd","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0130","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1128\/CMR.00117-13","article-title":"OXA \u03b2-lactamases","volume":"27","author":"Evans","year":"2014","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.medine.2022.05.004_bib0135","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1093\/jac\/dkaa513","article-title":"Class D \u03b2-lactamases","volume":"76","author":"Yoon","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0140","doi-asserted-by":"crossref","first-page":"e00102","DOI":"10.1128\/CMR.00102-19","article-title":"The global ascendency of OXA-48-type carbapenemases","volume":"33","author":"Pitout","year":"2019","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.medine.2022.05.004_bib0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1469-0691.2007.01860.x","article-title":"Extended-spectrum beta-lactamases and the permeability barrier","volume":"14 Suppl 1","author":"Mart\u00ednez-Mart\u00ednez","year":"2008","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medine.2022.05.004_bib0150","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.bbapap.2008.10.004","article-title":"Mechanisms of RND multidrug efflux pumps","volume":"1794","author":"Nikaido","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.medine.2022.05.004_bib0155","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00389-17","article-title":"Unusual Escherichia coli PBP 3 insertion sequence identified from a collection of carbapenem-resistant Enterobacteriaceae tested in vitro with a combination of ceftazidime-, ceftaroline-, or aztreonam-avibactam","volume":"61","author":"Zhang","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0160","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.medine.2022.05.004_bib0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mib.2020.01.002","article-title":"The evolution of MarR family transcription factors as counter-silencers in regulatory networks","volume":"55","author":"Will","year":"2020","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.medine.2022.05.004_bib0170","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/S0140-6736(97)07322-4","article-title":"Quinolone resistance from a transferable plasmid","volume":"351","author":"Mart\u00ednez-Mart\u00ednez","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.medine.2022.05.004_bib0175","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10156-010-0120-2","article-title":"Plasmid-mediated quinolone resistance: an update","volume":"17","author":"Rodr\u00edguez-Mart\u00ednez","year":"2011","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0180","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.drup.2010.08.003","article-title":"Aminoglycoside modifying enzymes","volume":"13","author":"Ramirez","year":"2010","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.medine.2022.05.004_bib0185","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.idc.2016.02.011","article-title":"Aminoglycoside resistance: the emergence of acquired 16S ribosomal RNA methyltransferases","volume":"30","author":"Doi","year":"2016","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.medine.2022.05.004_bib0190","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1093\/cid\/ciz640","article-title":"Plazomicin: a new aminoglycoside","volume":"70","author":"Saravolatz","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.medine.2022.05.004_bib0195","article-title":"Emergence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacterales in Spain studied by whole-genome sequencing","author":"Arca-Su\u00e1rez","year":"2021","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medine.2022.05.004_bib0200","article-title":"Current update on intrinsic and acquired colistin resistance mechanisms in bacteria","volume":"8","author":"Gogry","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.medine.2022.05.004_bib0205","doi-asserted-by":"crossref","first-page":"2897","DOI":"10.1007\/s11033-021-06307-y","article-title":"Mobilized colistin resistance (mcr) genes from 1 to 10: a comprehensive review","volume":"48","author":"Hussein","year":"2021","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.medine.2022.05.004_bib0210","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ijantimicag.2016.11.029","article-title":"Resistance to polymyxins in Gram-negative organisms","volume":"49","author":"Jeannot","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medine.2022.05.004_bib0215","doi-asserted-by":"crossref","first-page":"5521","DOI":"10.1128\/AAC.01480-13","article-title":"In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ\/PhoP mgrB regulator","volume":"57","author":"Cannatelli","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0220","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1128\/AAC.36.9.2046","article-title":"Interplay of impermeability and chromosomal beta-lactamase activity in imipenem-resistant Pseudomonas aeruginosa","volume":"36","author":"Livermore","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0034067","article-title":"The regulatory repertoire of Pseudomonas aeruginosa AmpC \u00df-lactamase regulator AmpR includes virulence genes","volume":"7","author":"Balasubramanian","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.medine.2022.05.004_bib0230","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1093\/jac\/dkv004","article-title":"Selection and molecular characterization of ceftazidime\/avibactam-resistant mutants in Pseudomonas aeruginosa strains containing derepressed AmpC","volume":"70","author":"Lahiri","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0235","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1093\/jac\/dkx424","article-title":"Mechanisms leading to in vivo ceftolozane\/tazobactam resistance development during the treatment of infections caused by MDR Pseudomonas aeruginosa","volume":"73","author":"Fraile-Ribot","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0240","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1128\/AAC.44.12.3322-3327.2000","article-title":"Substrate specificities of MexAB-OprM, MexCD-OprJ, and MexXY-oprM efflux pumps in Pseudomonas aeruginosa","volume":"44","author":"Masuda","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0245","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijantimicag.2015.03.001","article-title":"Emerging broad-spectrum resistance in Pseudomonas aeruginosa and Acinetobacter baumannii: mechanisms and epidemiology","volume":"45","author":"Potron","year":"2015","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medine.2022.05.004_bib0250","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1002\/iub.532","article-title":"Genetic basis of antibiotic resistance in pathogenic Acinetobacter species","volume":"63","author":"Poirel","year":"2011","journal-title":"IUBMB Life"},{"key":"10.1016\/j.medine.2022.05.004_bib0255","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/jac\/dkaa396","article-title":"Molecular mechanisms driving the in vivo development of OXA-10-mediated resistance to ceftolozane\/tazobactam and ceftazidime\/avibactam during treatment of XDR Pseudomonas aeruginosa infections","volume":"76","author":"Arca-Su\u00e1rez","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0260","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/jac\/47.3.247","article-title":"Of Pseudomonas, porins, pumps and carbapenems","volume":"47","author":"Livermore","year":"2001","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0265","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/ja.2006.31","article-title":"Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa","volume":"59","author":"Sakyo","year":"2006","journal-title":"J Antibiot"},{"key":"10.1016\/j.medine.2022.05.004_bib0270","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1093\/jac\/dkv228","article-title":"In vivo evolution of resistance of Pseudomonas aeruginosa strains isolated from patients admitted to an intensive care unit: mechanisms of resistance and antimicrobial exposure","volume":"70","author":"Sol\u00e9","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0275","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1128\/AAC.05451-11","article-title":"Alterations of OprD in carbapenem-intermediate and -susceptible strains of Pseudomonas aeruginosa isolated from patients with bacteremia in a Spanish multicenter study","volume":"56","author":"Ocampo-Sosa","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0280","doi-asserted-by":"crossref","first-page":"E369","DOI":"10.1111\/j.1469-0691.2012.03969.x","article-title":"Metallo-\u03b2-lactamase-producing Pseudomonas aeruginosa in the Netherlands: the nationwide emergence of a single sequence type","volume":"18","author":"Van der Bij","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medine.2022.05.004_bib0285","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drup.2016.09.001","article-title":"Plasmid-mediated quinolone resistance: two decades on","volume":"29","author":"Rodr\u00edguez-Mart\u00ednez","year":"2016","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.medine.2022.05.004_bib0290","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1128\/mr.57.1.138-163.1993","article-title":"Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes","volume":"57","author":"Shaw","year":"1993","journal-title":"Microbiol Rev"},{"key":"10.1016\/j.medine.2022.05.004_bib0295","doi-asserted-by":"crossref","first-page":"3202","DOI":"10.1128\/AAC.47.10.3202-3207.2003","article-title":"Contribution of the MexXY multidrug transporter to aminoglycoside resistance in Pseudomonas aeruginosa clinical isolates","volume":"47","author":"Sobel","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0300","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s11373-007-9194-y","article-title":"Aminoglycosides versus bacteria\u2013a description of the action, resistance mechanism, and nosocomial battleground","volume":"15","author":"Shakil","year":"2008","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.medine.2022.05.004_bib0305","doi-asserted-by":"crossref","first-page":"643","DOI":"10.3389\/fmicb.2014.00643","article-title":"Mechanisms of polymyxin resistance: acquired and intrinsic resistance in bacteria","volume":"5","author":"Olaitan","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.medine.2022.05.004_bib0310","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1128\/JB.00834-13","article-title":"The MerR-like regulator BrlR impairs Pseudomonas aeruginosa biofilm tolerance to colistin by repressing PhoPQ","volume":"195","author":"Chambers","year":"2013","journal-title":"J Bacteriol"},{"key":"10.1016\/j.medine.2022.05.004_bib0315","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1586\/eri.13.21","article-title":"Carbapenem resistance in Acinetobacter baumannii: laboratory challenges, mechanistic insights and therapeutic strategies","volume":"11","author":"Abbott","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.medine.2022.05.004_bib0320","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1586\/14787210.6.3.309","article-title":"Acinetobacter baumannii: an emerging multidrug-resistant threat","volume":"6","author":"Gootz","year":"2008","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.medine.2022.05.004_bib0325","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1469-0691.2005.01320.x","article-title":"Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii","volume":"12","author":"H\u00e9ritier","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.medine.2022.05.004_bib0330","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00309-15","article-title":"Contribution of resistance-nodulation-cell division efflux systems to antibiotic resistance and biofilm formation in Acinetobacter baumannii","volume":"6","author":"Yoon","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.medine.2022.05.004_bib0335","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3389\/fcimb.2017.00055","article-title":"Biology of Acinetobacter baumannii: pathogenesis, antibiotic resistance mechanisms, and prospective treatment options","volume":"7","author":"Lee","year":"2017","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.medine.2022.05.004_bib0340","first-page":"65","article-title":"Pseudomonas aeruginosa: resistance to the max","volume":"5","author":"Poole","year":"2011","journal-title":"Front Microbiol"},{"key":"10.1016\/j.medine.2022.05.004_bib0345","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1128\/AAC.01388-10","article-title":"Efflux-mediated antibiotic resistance in Acinetobacter spp","volume":"55","author":"Coyne","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0350","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1093\/jac\/dkr364","article-title":"A fluoroquinolone-resistant Acinetobacter baumannii without the quinolone resistance-determining region mutations","volume":"66","author":"Chopra","year":"2011","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0355","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/AAC.00732-07","article-title":"AdeIJK, a resistance\u2013nodulation\u2013cell division pump effluxing multiple antibiotics in Acinetobacter baumannii","volume":"52","author":"Damier-Piolle","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0360","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.diagmicrobio.2009.02.010","article-title":"Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals","volume":"64","author":"Cho","year":"2009","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.medine.2022.05.004_bib0365","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1157\/13085012","article-title":"Prevalencia de los genes tetA y tetB como mecanismo de resistencia a tetraciclina y minociclina en aislamientos cl\u00ednicos de Acinetobacter baumannii","volume":"24","author":"Mart\u00ed","year":"2006","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1016\/j.medine.2022.05.004_bib0370","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1128\/AAC.01727-13","article-title":"Molecular epidemiology and mechanisms of tigecycline resistance in clinical isolates of Acinetobacter baumannii from a Chinese university hospital","volume":"58","author":"Deng","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0375","doi-asserted-by":"crossref","first-page":"3370","DOI":"10.1128\/AAC.00079-11","article-title":"Phosphoethanolamine modification of lipid A in colistin-resistant variants of Acinetobacter baumannii mediated by the pmrAB two-component regulatory system","volume":"55","author":"Beceiro","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0380","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1128\/AAC.00834-10","article-title":"Colistin resistance in Acinetobacter baumannii is mediated by complete loss of lipopolysaccharide production","volume":"54","author":"Moffatt","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0385","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ijantimicag.2016.11.029","article-title":"Resistance to polymyxins in Gram-negative organisms","volume":"49","author":"Jeannot","year":"2017","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.medine.2022.05.004_bib0390","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1128\/CMR.11.1.57","article-title":"Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia","volume":"11","author":"Denton","year":"1998","journal-title":"Clin Microb Rev"},{"key":"10.1016\/j.medine.2022.05.004_bib0395","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1128\/AAC.44.11.3079-3086.2000","article-title":"Cloning and characterization of SmeDEF, a novel efflux pump from Stenotrophomonas maltophilia","volume":"44","author":"Alonso","year":"2000","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0400","doi-asserted-by":"crossref","first-page":"R74","DOI":"10.1186\/gb-2008-9-4-r74","article-title":"The complete genome, comparative and functional analysis of Stenotrophomonas maltophilia reveals an organism heavily shielded by drug resistance determinants","volume":"9","author":"Crossman","year":"2008","journal-title":"Genome Biol"},{"key":"10.1016\/j.medine.2022.05.004_bib0405","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1128\/AAC.00496-09","article-title":"SmQnr contributes to intrinsic resistance to quinolones in Stenotrophomonas maltophilia","volume":"54","author":"S\u00e1nchez","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.medine.2022.05.004_bib0410","article-title":"Increase in the prevalence of resistance determinants to trimethoprim\/sulfamethoxazole in clinical Stenotrophomonas maltophilia isolates in China","volume":"11","author":"Hu","year":"2016","journal-title":"PLoS One"}],"container-title":["Medicina Intensiva (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173572722000947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173572722000947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T02:35:49Z","timestamp":1761878149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173572722000947"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":82,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2173572722000947"],"URL":"https:\/\/doi.org\/10.1016\/j.medine.2022.05.004","relation":{},"ISSN":["2173-5727"],"issn-type":[{"value":"2173-5727","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Resistance mechanisms in Gram-negative bacteria","name":"articletitle","label":"Article Title"},{"value":"Medicina Intensiva (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medine.2022.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.medin.2022.02.004","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Espa\u00f1a,  S.L.U. and SEMICYUC. All rights reserved.","name":"copyright","label":"Copyright"}]}}